Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Use of optical coherence tomography to evaluate papilledema and pseudopapilledema.

Heidary G, Rizzo JF 3rd.

Semin Ophthalmol. 2010 Sep-Nov;25(5-6):198-205. doi: 10.3109/08820538.2010.518462. Review.

PMID:
21091000
2.

Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.

Skau M, Yri H, Sander B, Gerds TA, Milea D, Jensen R.

Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):567-74. doi: 10.1007/s00417-012-2039-z. Epub 2012 May 18.

PMID:
22592348
3.

Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.

Rebolleda G, Muñoz-Negrete FJ.

Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5197-200. doi: 10.1167/iovs.08-2528. Epub 2008 Nov 14.

PMID:
19011007
4.

OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.

Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, Jin YP.

Clin Neurol Neurosurg. 2015 Mar;130:122-7. doi: 10.1016/j.clineuro.2014.12.021. Epub 2015 Jan 7.

PMID:
25614195
5.

OCT for optic disc evaluation in idiopathic intracranial hypertension.

Skau M, Milea D, Sander B, Wegener M, Jensen R.

Graefes Arch Clin Exp Ophthalmol. 2011 May;249(5):723-30. doi: 10.1007/s00417-010-1527-2. Epub 2010 Oct 15.

PMID:
20949278
6.

[Utility of optic coherence tomography (OCT) in the follow-up of idiopathic intracranial hypertension in childhood].

Sánchez-Tocino H, Bringas R, Iglesias D, González-Pérez A, Del Villar-Galán R.

Arch Soc Esp Oftalmol. 2006 Jul;81(7):383-9. Spanish.

PMID:
16888691
7.

Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study.

Skau M, Sander B, Milea D, Jensen R.

J Neurol. 2011 Feb;258(2):277-83. doi: 10.1007/s00415-010-5750-x. Epub 2010 Sep 19.

PMID:
20853113
8.

Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Yri HM, Wegener M, Sander B, Jensen R.

J Neurol. 2012 May;259(5):886-94. doi: 10.1007/s00415-011-6273-9. Epub 2011 Oct 19.

PMID:
22008872
9.

Long-term evolution of papilledema in idiopathic intracranial hypertension: observations concerning two cases.

Piovesan EJ, Lange MC, Piovesan Ldo R, de Almeida SM, Kowacs PA, Werneck LC.

Arq Neuropsiquiatr. 2002 Jun;60(2-B):453-7.

10.

Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.

Optical Coherence Tomography Substudy Committee; NORDIC Idiopathic Intracranial Hypertension Study Group.

Ophthalmology. 2015 Sep;122(9):1939-45.e2. doi: 10.1016/j.ophtha.2015.06.003. Epub 2015 Jul 18.

11.

OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension.

Waisbourd M, Leibovitch I, Goldenberg D, Kesler A.

Clin Neurol Neurosurg. 2011 Dec;113(10):839-43. doi: 10.1016/j.clineuro.2011.05.015. Epub 2011 Jun 22.

PMID:
21700384
12.

Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis.

Marzoli SB, Ciasca P, Curone M, Cammarata G, Melzi L, Criscuoli A, Bussone G, D'Amico D.

Neurol Sci. 2013 May;34 Suppl 1:S143-5. doi: 10.1007/s10072-013-1373-1.

PMID:
23695066
13.

Optical coherence tomography in papilledema: what am I missing?

Kardon R.

J Neuroophthalmol. 2014 Sep;34 Suppl:S10-7. doi: 10.1097/WNO.0000000000000162. Review.

PMID:
25133965
14.

[Optical coherence tomography and intracranial hypertension].

Bidot S, Vasseur V, Vignal-Clermont C.

J Fr Ophtalmol. 2013 Mar;36(3):277-85. doi: 10.1016/j.jfo.2012.11.006. Epub 2013 Feb 26. Review. French.

15.

Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT.

Kaufhold F, Kadas EM, Schmidt C, Kunte H, Hoffmann J, Zimmermann H, Oberwahrenbrock T, Harms L, Polthier K, Brandt AU, Paul F.

PLoS One. 2012;7(5):e36965. doi: 10.1371/journal.pone.0036965. Epub 2012 May 15.

16.

Pseudopapilledema and association with idiopathic intracranial hypertension.

Liu B, Murphy RK, Mercer D, Tychsen L, Smyth MD.

Childs Nerv Syst. 2014 Jul;30(7):1197-200. doi: 10.1007/s00381-014-2390-y. Epub 2014 Feb 27.

PMID:
24573961
17.

Retinal and Choroidal Folds in Papilledema.

Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M; OCT Substudy Group for the NORDIC Idiopathic Intracranial Hypertension Treatment Trial.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5670-80. doi: 10.1167/iovs.15-17459.

18.

Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.

Gospe SM 3rd, Bhatti MT, El-Dairi MA.

Br J Ophthalmol. 2016 Apr;100(4):505-9. doi: 10.1136/bjophthalmol-2015-307043. Epub 2015 Aug 12.

PMID:
26269534
19.

Undiagnosed papilledema in a morbidly obese patient population: a prospective study.

Krispel CM, Keltner JL, Smith W, Chu DG, Ali MR.

J Neuroophthalmol. 2011 Dec;31(4):310-5. doi: 10.1097/WNO.0b013e3182269910.

PMID:
21799447
20.

[Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].

Jeanjean L, Castelnovo G, Carlander B, Villain M, Mura F, Dupeyron G, Labauge P.

Rev Neurol (Paris). 2008 Nov;164(11):927-34. doi: 10.1016/j.neurol.2008.03.008. Epub 2008 Jun 6. French.

PMID:
18808761

Supplemental Content

Support Center